Latest news with #MarjorieTaylorGreene
Fox News
an hour ago
- General
- Fox News
Marjorie Taylor Greene slams FDA green lighting of mNEXSPIKE COVID-19 vaccine: 'Not MAHA at all!!!'
Rep. Marjorie Taylor Greene, R-Ga., slammed the U.S. Food and Drug Administration's move to give the green light to Moderna's mNEXSPIKE COVID-19 vaccine. "Not MAHA at all!!!," the congresswoman wrote in a post on X, using the acronym for the phrase "Make America Healthy Again," calling the move "Unreal." "MNEXSPIKE is approved for use in individuals who have been previously vaccinated with any COVID-19 vaccine and are 65 years of age and older, or 12 years through 64 years of age with at least one underlying condition that puts them at high risk for severe outcomes from COVID-19," an FDA letter to Moderna notes. According to a Moderna press release, CEO Stéphane Bancel said that "COVID-19 remains a serious public health threat, with more than 47,000 Americans dying from the virus last year alone." The company describes itself as "a leader in the creation of the field of mRNA medicine." Greene has previously spoken out against COVID-19 vaccines, saying their FDA approval should be nixed. "COVID-19 vaccines should have never received approval and they've known the entire time how bad the side effects are and deaths caused by them. It's time to do the right thing. Stop the COVID-19 vaccines," she declared in part of a tweet in March. The congresswoman is currently serving her third term in the House of Representatives.
Newsweek
3 hours ago
- Health
- Newsweek
Marjorie Taylor Greene Fumes Over Vaccine Approval: 'Not MAHA at All'
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Marjorie Taylor Greene has spoken out against a new COVID-19 vaccine being approved in the United States, saying the move is "not MAHA at all." Why It Matters Health Secretary Robert F. Kennedy Jr. is facing repeated backlash for some of his positions on health and medicine, including from people who would ordinarily support him. In May, prominent members of the Make America Great Again movement, including Nicole Shanahan, Kennedy's former presidential running mate, and media personality Laura Loomer, spoke out against Kennedy Jr.'s pick for U.S. Surgeon General Casey Means. In March, Kennedy Jr. sparked anger from anti-vax activists when he called on parents to "consult with their healthcare providers to understand their options to get the MMR vaccine," with one saying he is "no different than Fauci." Marjorie Taylor Greene, R-Ga., arrives for a meeting of House Republicans in the Capitol Visitor Center on May 15, 2025. Marjorie Taylor Greene, R-Ga., arrives for a meeting of House Republicans in the Capitol Visitor Center on May 15, 2025. AP What To Know The U.S. Food and Drug Administration (FDA) gave the green light for mNEXSPIKE (mRNA-1283), Moderna's new lower-dose COVID-19 vaccine, on May 31. Greene, the U.S. representative for Georgia's 14th congressional district, shared Moderna's post about the recent approval with the caption: "Not MAHA at all!!! Unreal." Not MAHA at all!!! Unreal. — Rep. Marjorie Taylor Greene🇺🇸 (@RepMTG) June 1, 2025 She was referring to Kennedy Jr.'s movement Make America Healthy Again, whose mission is to "aggressively combat the critical health challenges facing our citizens, including the rising rates of mental health disorders, obesity, diabetes, and other chronic diseases." Newsweek has contacted the United States Department of Health and Human Services outside of office hours, via email, for comment. The new vaccine is set to be used for adults 65 or older or people between the ages of 12 and 64 with at least one or more underlying risk factor as defined by the Centers for Disease Control and Prevention (CDC). Approval for the jab is "based on results from a randomized, observer-blind, active-controlled Phase 3 clinical trial which enrolled approximately 11,400 participants aged 12 years and older," Moderna says. It comes after Kennedy Jr. announced that the CDC is no longer encouraging COVID-19 vaccines for pregnant women and healthy children, marking a shift in federal public health guidance. What People Are Saying Chief Executive Officer of Moderna Stéphane Bancel said in a statement: "The FDA approval of our third product, mNEXSPIKE, adds an important new tool to help protect people at high risk of severe disease from COVID-19. "COVID-19 remains a serious public health threat, with more than 47,000 Americans dying from the virus last year alone. We appreciate the FDA's timely review and thank the entire Moderna team for their hard work and continued commitment to public health." Kennedy Jr. said about the new CDC guidance: "I couldn't be more pleased to announce that as of today the COVID vaccine for healthy children and healthy pregnant women has been removed from the CDC recommended immunization schedule." What Happens Next The new vaccine is expected to be ready for those eligible to take it in time for the 2025-2026 respiratory virus season. You should not get mNEXSPIKE if you had a severe allergic reaction after a previous dose of either mNEXSPIKE, SPIKEVAX (an mRNA vaccine for preventing COVID-19) or any Moderna COVID-19 vaccine or to any ingredient in these vaccines, the company warns.
Newsweek
3 days ago
- Politics
- Newsweek
Rep. Tried To Give MTG Cheez-Its During Meeting: 'Maybe She's Hangry'
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. A Democratic Representative tried to pass Republican Representative Marjorie Taylor Greene Cheez-Its during a meeting, she has claimed. Speaking toRaw Story, New Mexico Democrat Melanie Stansbury, who sat on the Georgia Republican's Delivering Government Efficiency Subcommittee, outlined her relationship with Taylor Greene and recalled a moment she tried to share cheese-baked snacks with her colleague. Newsweek contacted Taylor Greene's representatives by email to comment on this story. Why It Matters In November 2024, Taylor Greene was picked to lead a subcommittee of the newly created Department of Government Efficiency. UNITED STATES - MAY 20: Rep. Marjorie Taylor Greene, R-Ga., makes her way to a House Republican Conference meeting with President Donald Trump on the budget reconciliation bill in the U.S. Capitol on Tuesday, May... UNITED STATES - MAY 20: Rep. Marjorie Taylor Greene, R-Ga., makes her way to a House Republican Conference meeting with President Donald Trump on the budget reconciliation bill in the U.S. Capitol on Tuesday, May 20, 2025. More Tom Williams/CQ Roll Call via AP Images The committee investigated so-called wasteful spending, examined ways to reorganize federal agencies to improve efficiency and identified solutions to eliminate bureaucratic red tape. It was linked to DOGE, run by Elon Musk, to streamline government spending. What To Know Stansbury said working with Taylor Greene had started off "fairly collegial" and that the Georgia Republican had displayed "very nice, very warm" behavior and "southern hospitality." However, she said that despite initially agreeing to work in a bipartisan manner, the subcommittee "devolved into madness very quickly." "We had a crazy hearing at the start of May where they were attacking trans athletes, and she was just so out of control. Later — that was the week she announced she wasn't running for Senate — I knew something was wrong with her that day, because she was acting so stressed out," she said. She continued: "Even halfway through that hearing, I tried to slip her some Cheez-Its because I was like, 'Maybe she's hangry?'" Stansbury said. I'm like, 'I don't know why she's acting this way.'" Stansbury also called Musk a "bull****ter" who had "no idea what he was doing." She called the Tesla boss "a fraud" and said DOGE plans were "sloppy, stupid, uncoordinated and ineffective." What People Are Saying Mark Shanahan, an American politics expert who teaches at the University of Surrey in the U.K, told Newsweek: "We're in a period of yo-yo polling, often among the same demographics, which pretty much reflects While Congressional adversaries like to keep up the image of avowed political enemies for the public, the reality is that they tend to be a little more collegiate when the spotlight's not on them. MTG is more performative than most, but I'm sure even she's not averse to the odd cheesy snack. Stansbury doubtless aimed to take the wind out of the Republican firebrand sails - but at least she managed to do so with a little humour." Melanie Stansbury, after being named ranking member on the subcommittee: "We know there are broadly-supported, bi-partisan solutions that will improve government efficiency and transparency and I am ready to work together to find meaningful solutions. I am honored to be named the lead Democrat on this committee and have the opportunity to tackle the significant issues we have ahead of us." What Happens Next The committee continues having hearings and meetings. Whether Taylor Greene will receive more snacks during these meetings remains to be seen.
Yahoo
5 days ago
- Business
- Yahoo
Opinion - Banning stock trading in Congress is a crucial step toward restoring public trust
A group of Senate Democrats recently announced they will re-introduce a bill to ban stock trading by members of Congress and their families. The renewed call comes about a month after members of Congress, including Rep. Marjorie Taylor Greene (R-Ga.), disclosed large stock purchases just before the Trump administration announced a 90-day pause on tariffs when the market jumped 10 percent. As many know, this problem occurs on both sides of the aisle. During the COVID-19 pandemic, then-House Speaker Nancy Pelosi (D-Calif.) was scrutinized for timely trades made by her husband, just before major federal aid packages and lockdowns were announced. While accusations of insider trading by members of Congress are a familiar story, what we haven't known, until now, is what exactly these beliefs do to public trust in the federal government as well as how it impacts the public's willingness to follow the laws passed by these same members of Congress. Alongside psychologist Tage Rai, I ran a series of experiments with over 1,000 Americans to find out. We found that when people learn about members of Congress making unusual gains from stock trades, it makes them lose faith in Congress. They see lawmakers as more corrupt, less trustworthy, and less legitimate. And most critically, they feel less obligated to follow federal laws themselves. Interestingly, we found that this isn't just about resentment over politicians making money. In a follow-up experiment, we shared information with our participants on a fictional lawmaker who lost money on stock trades. The results were the same. It didn't matter if members of Congress made or lost money, they didn't like the idea that elected officials were trading in the market they govern. The sense of unfairness cuts across party lines, which may be why fixing it is one of the few issues with rare bipartisan support, not just from voters, but from lawmakers themselves. In addition to Democratic members of Congress like Sens. Jon Ossoff (D-Ga.), Mark Kelly (D-Ariz.), and Elizabeth Warren (D-Mass.) and Rep. Alexandria Ocasio-Cortez of New York; and Republicans like Rep. Chip Roy (R-Texas), Sen. Josh Hawley (R-Mo.), and even Speaker Mike Johnson (R-La.) have all backed reforms. Among ordinary Americans, more than 86 percent of both Democrats and Republicans support banning stock trading by members of Congress. We already have laws on the books. The STOCK Act requires members of Congress to disclose their trades, but enforcement is weak and penalties are trivial. The most recent bill from Ossoff and Kelly advocates for stronger measures requiring members of Congress to place their assets and their family's assets in blind trusts, with others responsible for managing their portfolios. In psychology, there's a concept called a credibility-enhancing display — a costly action that signals someone truly believes in what he or she is doing. For example, some religious people engage in rituals like fasting. Some environmental activists forgo air travel. Such acts demonstrate genuine commitment and inspire others in the service of their cause. If politicians voluntarily regulate themselves, it could send that same kind of signal. Banning insider trading would do more than prevent corruption: it would show the American public that their lawmakers are willing to incur personal costs to serve the public good with integrity. Social scientists have long asked why some countries flourish while others stagnate. Last year, economists Daron Acemoglu and Simon Johnson, along with political scientist James Robinson, won the Nobel Prize for showing that the answer lies in political institutions — whether they are inclusive and accountable, or extractive and self-serving. For a long time, researchers have held the U.S. as a global model: a country that was prosperous because of strong and respected institutions. Corruption was something we studied in other countries. That reality has been fading. Banning congressional stock trading won't fix everything, but it's a rare bipartisan opportunity to restore public trust and to prove that the rules still apply to those in power. Raihan Alam is a doctoral student in management at the University of California-San Diego Rady School of Management. He is first author of the paper 'Knowledge of Politician Stock Trading Reduces Congressional Legitimacy and Compliance with the Law,' published in Proceedings of the National Academy of Sciences. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
The Hill
5 days ago
- Business
- The Hill
Banning stock trading in Congress is a crucial step toward restoring public trust
A group of Senate Democrats recently announced they will re-introduce a bill to ban stock trading by members of Congress and their families. The renewed call comes about a month after members of Congress, including Rep. Marjorie Taylor Greene (R-Ga.), disclosed large stock purchases just before the Trump administration announced a 90-day pause on tariffs when the market jumped 10 percent. As many know, this problem occurs on both sides of the aisle. During the COVID-19 pandemic, then-House Speaker Nancy Pelosi (D-Calif.) was scrutinized for timely trades made by her husband, just before major federal aid packages and lockdowns were announced. While accusations of insider trading by members of Congress are a familiar story, what we haven't known, until now, is what exactly these beliefs do to public trust in the federal government as well as how it impacts the public's willingness to follow the laws passed by these same members of Congress. Alongside psychologist Tage Rai, I ran a series of experiments with over 1,000 Americans to find out. We found that when people learn about members of Congress making unusual gains from stock trades, it makes them lose faith in Congress. They see lawmakers as more corrupt, less trustworthy, and less legitimate. And most critically, they feel less obligated to follow federal laws themselves. Interestingly, we found that this isn't just about resentment over politicians making money. In a follow-up experiment, we shared information with our participants on a fictional lawmaker who lost money on stock trades. The results were the same. It didn't matter if members of Congress made or lost money, they didn't like the idea that elected officials were trading in the market they govern. The sense of unfairness cuts across party lines, which may be why fixing it is one of the few issues with rare bipartisan support, not just from voters, but from lawmakers themselves. In addition to Democratic members of Congress like Sens. Jon Ossoff (D-Ga.), Mark Kelly (D-Ariz.), and Elizabeth Warren (D-Mass.) and Rep. Alexandria Ocasio-Cortez of New York; and Republicans like Rep. Chip Roy (R-Texas), Sen. Josh Hawley (R-Mo.), and even Speaker Mike Johnson (R-La.) have all backed reforms. Among ordinary Americans, more than 86 percent of both Democrats and Republicans support banning stock trading by members of Congress. We already have laws on the books. The STOCK Act requires members of Congress to disclose their trades, but enforcement is weak and penalties are trivial. The most recent bill from Ossoff and Kelly advocates for stronger measures requiring members of Congress to place their assets and their family's assets in blind trusts, with others responsible for managing their portfolios. In psychology, there's a concept called a credibility-enhancing display — a costly action that signals someone truly believes in what he or she is doing. For example, some religious people engage in rituals like fasting. Some environmental activists forgo air travel. Such acts demonstrate genuine commitment and inspire others in the service of their cause. If politicians voluntarily regulate themselves, it could send that same kind of signal. Banning insider trading would do more than prevent corruption: it would show the American public that their lawmakers are willing to incur personal costs to serve the public good with integrity. Social scientists have long asked why some countries flourish while others stagnate. Last year, economists Daron Acemoglu and Simon Johnson, along with political scientist James Robinson, won the Nobel Prize for showing that the answer lies in political institutions — whether they are inclusive and accountable, or extractive and self-serving. For a long time, researchers have held the U.S. as a global model: a country that was prosperous because of strong and respected institutions. Corruption was something we studied in other countries. That reality has been fading. Banning congressional stock trading won't fix everything, but it's a rare bipartisan opportunity to restore public trust and to prove that the rules still apply to those in power. Raihan Alam is a doctoral student in management at the University of California-San Diego Rady School of Management. He is first author of the paper ' Knowledge of Politician Stock Trading Reduces Congressional Legitimacy and Compliance with the Law,' published in Proceedings of the National Academy of Sciences.
